Health
MS lifeline as drug that can slow disease listed – Chinchilla News
Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.
Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News23 hours agoNicole Kidman Is Back in Wellness Guru Mode: ‘Nine Perfect Strangers’ Season Two Will Hit Your Streaming Queue in May
-
Noosa News22 hours agoDevastating update in search for missing Queensland mother Tayla Spies as police find human remains near her ute
-
Noosa News23 hours agoDingoes bite 3 women on K’gari